Caleres (NYSE:CAL) Reaches New 52-Week Low – Here’s What Happened

Shares of Caleres, Inc. (NYSE:CALGet Free Report) reached a new 52-week low during trading on Thursday . The stock traded as low as $16.03 and last traded at $16.04, with a volume of 19679 shares traded. The stock had previously closed at $16.55.

Analysts Set New Price Targets

Separately, Loop Capital lowered their target price on shares of Caleres from $30.00 to $25.00 and set a “hold” rating for the company in a research note on Friday, December 6th.

Read Our Latest Stock Report on CAL

Caleres Trading Up 0.9 %

The company’s 50 day moving average price is $19.45 and its 200-day moving average price is $28.19. The company has a market capitalization of $543.61 million, a PE ratio of 3.60 and a beta of 1.92.

Caleres (NYSE:CALGet Free Report) last announced its quarterly earnings data on Thursday, December 5th. The textile maker reported $1.23 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.38 by ($0.15). Caleres had a net margin of 5.69% and a return on equity of 22.71%. The company had revenue of $740.90 million for the quarter, compared to analysts’ expectations of $751.35 million. During the same period in the prior year, the firm earned $1.37 earnings per share. The firm’s quarterly revenue was down 2.8% on a year-over-year basis. As a group, analysts predict that Caleres, Inc. will post 3.23 earnings per share for the current year.

Caleres Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, January 10th. Stockholders of record on Friday, December 27th were paid a dividend of $0.07 per share. The ex-dividend date was Friday, December 27th. This represents a $0.28 annualized dividend and a dividend yield of 1.73%. Caleres’s dividend payout ratio is presently 6.24%.

Insider Buying and Selling

In other news, Director Kyle Gendreau acquired 5,000 shares of the business’s stock in a transaction on Friday, January 17th. The shares were purchased at an average price of $19.93 per share, for a total transaction of $99,650.00. Following the acquisition, the director now directly owns 5,000 shares of the company’s stock, valued at $99,650. This represents a ∞ increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. 3.80% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Caleres

Institutional investors have recently added to or reduced their stakes in the company. Universal Beteiligungs und Servicegesellschaft mbH acquired a new stake in shares of Caleres in the 4th quarter valued at about $1,616,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its stake in Caleres by 31.7% during the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 100,962 shares of the textile maker’s stock worth $2,338,000 after acquiring an additional 24,316 shares during the period. Voloridge Investment Management LLC acquired a new stake in Caleres during the fourth quarter worth about $8,259,000. Vident Advisory LLC raised its stake in Caleres by 32.6% during the fourth quarter. Vident Advisory LLC now owns 15,918 shares of the textile maker’s stock worth $369,000 after acquiring an additional 3,912 shares during the period. Finally, Tidal Investments LLC acquired a new stake in Caleres during the fourth quarter worth about $406,000. Institutional investors and hedge funds own 98.44% of the company’s stock.

Caleres Company Profile

(Get Free Report)

Caleres, Inc engages in the retail and wholesale of footwear business in the United States, Canada, East Asia, and internationally. It operates through Famous Footwear and Brand Portfolio segments. The company offers licensed, branded, and private-label athletic, casual, and dress footwear products. The company provides brand name athletic, casual, and dress shoes, including Nike, Skechers, adidas, Vans, Crocs, Converse, Puma, Birkenstock, New Balance, Under Armour, Dr.

Featured Articles

Receive News & Ratings for Caleres Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Caleres and related companies with MarketBeat.com's FREE daily email newsletter.